Registry for real-world data on prostate cancer
Patient Reported Data on Prostate Cancer Diagnosis, Management, and Outcome: Real World Prostate Cancer Registry
This study is gathering real-life information from men with prostate cancer in the tristate area to see how their treatment and outcomes vary over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Cincinnati Cancer Advisors Research network |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT06355336 on ClinicalTrials.gov |
What this trial studies
The Real World Prostate Cancer Registry aims to collect comprehensive real-world data from patients diagnosed with prostate cancer in the tristate area. This observational study will gather information on patient demographics, disease characteristics, management approaches, and outcomes over a period of ten years, including three years of enrollment and seven years of follow-up. Patients will provide e-consent and complete online forms, with reminders for follow-up submissions. The study seeks to identify patterns in prostate cancer management and outcomes, as well as gaps in care delivery.
Who should consider this trial
Good fit: Ideal candidates include men aged 18 and older with pathologically confirmed primary prostate cancer diagnosed within the last 12 months who reside in the tristate area.
Not a fit: Patients with other cancer diagnoses (except for squamous cell skin cancer) or those who refuse to sign the consent form may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of prostate cancer management and improve patient outcomes through better-informed treatment strategies.
How similar studies have performed: While similar observational studies have been conducted, this registry focuses specifically on real-world data collection for prostate cancer, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients with pathologically confirmed primary prostate cancer Diagnosis since January 1st, 2023 Acceptance to sign the consent form 18 years old or older Resident of Ohio, Kentucky or Indiana Exclusion Criteria: Having diagnosis of other cancer except squamous cell cancer of the skin Refusal to sign a consent form.
Where this trial is running
Cincinnati, Ohio
- Cincinnati Cancer Advisors — Cincinnati, Ohio, United States (Recruiting)
Study contacts
- Study coordinator: Abdul Jazieh, MD, MPH
- Email: a.jazieh@cincinnaticanceradvisors.org
- Phone: 5137312273
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.